Fatigue Management Programs for People With MS
Primary Purpose
Multiple Sclerosis
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Teleconference
Internet
1-to-1, in-person
Sponsored by
About this trial
This is an interventional treatment trial for Multiple Sclerosis focused on measuring Fatigue, Wellness, Multiple Sclerosis, Quality of life
Eligibility Criteria
Inclusion Criteria:
- Self-report diagnosis of MS
- Age ≥ 18 years
- Fatigue Severity Scale score ≥ 4
- Ability to speak English
Exclusion Criteria:
- Individual must be capable of providing consent (Assessed with questionnaire)
- Unable to access the internet or unable to travel to in-person sessions
Sites / Locations
- University of Illinois at Chicago
- University of Minnesota
- Case Western Reserve University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
Teleconference
Internet
I-to-1, in-person
Arm Description
Teleconference Intervention arm
Internet Intervention arm
1-to-1, in-person intervention arm
Outcomes
Primary Outcome Measures
Change from Baseline in fatigue levels
Fatigue will be assessed with Fatigue Impact Scale. Fatigue Impact Scale is a 40-item questionnaire that measures impact of fatigue on day-to-day life. Scale ranges from "no problem" (0) to "extreme problem" (4). Total scores will be computed by summing responses for each item. Scores can range from 0 to 160.
Secondary Outcome Measures
Change from Baseline in quality of life will be assessed
Multiple Sclerosis Impact Scale and Community Participation Indicators will be used.
Multiple Sclerosis Impact Scale is considered measure of health-related quality of life. It consists of 29 self-report questions that includes 2 subscales: physical function and mental function.
Community Participation Indicators consists of 20 questions about various social activities and community roles. Participants are asked to rate their frequency of engagement, whether it was important, and whether they were doing it enough.
Full Information
NCT ID
NCT03550170
First Posted
May 24, 2018
Last Updated
January 30, 2023
Sponsor
Case Western Reserve University
Collaborators
Patient-Centered Outcomes Research Institute, University of Illinois at Chicago, University of Minnesota, Queen's University, Kingston, Ontario, Dalhousie University, The Cleveland Clinic
1. Study Identification
Unique Protocol Identification Number
NCT03550170
Brief Title
Fatigue Management Programs for People With MS
Official Title
Comparing the Effectiveness of Fatigue Management Programs for People With MS
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 1, 2019 (Actual)
Primary Completion Date
April 28, 2023 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Case Western Reserve University
Collaborators
Patient-Centered Outcomes Research Institute, University of Illinois at Chicago, University of Minnesota, Queen's University, Kingston, Ontario, Dalhousie University, The Cleveland Clinic
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a multi-site randomized clinical trial comparing 3 modes of delivering the Managing Fatigue course for reducing fatigue in individuals with multiple sclerosis (MS). The primary hypothesis is that the teleconference and internet versions of the course will be noninferior to the one-on-one, in person version in terms of the primary outcome of fatigue and secondary outcome of quality of life.
Detailed Description
Fatigue is one of the most common and debilitating symptoms of multiple sclerosis (MS). MS fatigue can impact all aspects of quality of life, including physical, mental, and social function. MS fatigue is a profound barrier to participating in meaningful activities, such as employment and hobbies. Currently, the FDA has not approved medications for MS fatigue in the United States (US). However, there are empirically tested, non-pharmacological strategies that can support people with MS in reducing the impact of fatigue. Thus, the aim of the study is to compare 3 modes of delivering the Managing Fatigue course-2 telerehabilitation formats (teleconference and internet) and 1-to-1, in-person format (traditional mode of clinical service delivery)-upon outcomes important to people with MS, i.e., fatigue and its impact on physical, mental, and social function. The intervention arms will focus on reducing fatigue as a strategy to directly improve physical, mental and social functioning.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
Keywords
Fatigue, Wellness, Multiple Sclerosis, Quality of life
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
582 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Teleconference
Arm Type
Active Comparator
Arm Description
Teleconference Intervention arm
Arm Title
Internet
Arm Type
Active Comparator
Arm Description
Internet Intervention arm
Arm Title
I-to-1, in-person
Arm Type
Active Comparator
Arm Description
1-to-1, in-person intervention arm
Intervention Type
Behavioral
Intervention Name(s)
Teleconference
Intervention Description
This intervention arm will be a 6-week, group-based course involving weekly 80-min teleconference sessions. It will be delivered in small groups (6-12 participants) to maximize participants' opportunities for interaction. A program manual divided into 6 sections, 1 for each week that includes worksheets and homework activities will be given to the participants. Occupational therapists will facilitate the sessions. Participants and the OT will dial into 1-800 conference call line on the designated date and time.
Intervention Type
Behavioral
Intervention Name(s)
Internet
Intervention Description
The internet course is similar to the teleconference format. It will occur in a 6-week period and be group based; i.e., 8-12 participants will begin the intervention at the same time and interact with each other during the 6-week period. Participants will be given a username and a password to view a different session each week at a time convenient for them. Each session will include completing practice activities and sharing information (e.g., offering advice and support to one another through the discussion forum). OTs will facilitate the discussions by responding to entries, asking questions, and providing encouragement to complete sessions.
Intervention Type
Behavioral
Intervention Name(s)
1-to-1, in-person
Intervention Description
Unlike the teleconference and internet courses, the number and length of sessions for the 1-to-1, in-person course will vary over the 6-week period. The OT will cover all 6 topics, but the pace will be tailored to the participants' needs and preferences. Thus, although the topics are consistent, OTs are able to spend more time on topics that participants find pertinent to their situations. The participant and OT will be instructed to meet at least 3 times with at least 7 days between each session.
Primary Outcome Measure Information:
Title
Change from Baseline in fatigue levels
Description
Fatigue will be assessed with Fatigue Impact Scale. Fatigue Impact Scale is a 40-item questionnaire that measures impact of fatigue on day-to-day life. Scale ranges from "no problem" (0) to "extreme problem" (4). Total scores will be computed by summing responses for each item. Scores can range from 0 to 160.
Time Frame
Each patient will be given the assessments at 4 points during the study, at baseline, 8 weeks, 3 months, and 6 months
Secondary Outcome Measure Information:
Title
Change from Baseline in quality of life will be assessed
Description
Multiple Sclerosis Impact Scale and Community Participation Indicators will be used.
Multiple Sclerosis Impact Scale is considered measure of health-related quality of life. It consists of 29 self-report questions that includes 2 subscales: physical function and mental function.
Community Participation Indicators consists of 20 questions about various social activities and community roles. Participants are asked to rate their frequency of engagement, whether it was important, and whether they were doing it enough.
Time Frame
Each patient will be given the assessments at 4 points during the study, at baseline, 8 weeks, 3 months, and 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Self-report diagnosis of MS
Age ≥ 18 years
Fatigue Severity Scale score ≥ 4
Ability to speak English
Exclusion Criteria:
Individual must be capable of providing consent (Assessed with questionnaire)
Unable to access the internet or unable to travel to in-person sessions
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Matthew Plow, PhD
Organizational Affiliation
Case Western Reserve University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Illinois at Chicago
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60612
Country
United States
Facility Name
University of Minnesota
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55455
Country
United States
Facility Name
Case Western Reserve University
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
32801193
Citation
Plow M, Packer T, Mathiowetz VG, Preissner K, Ghahari S, Sattar A, Bethoux F, Finlayson M. REFRESH protocol: a non-inferiority randomised clinical trial comparing internet and teleconference to in-person 'Managing Fatigue' interventions on the impact of fatigue among persons with multiple sclerosis. BMJ Open. 2020 Aug 16;10(8):e035470. doi: 10.1136/bmjopen-2019-035470.
Results Reference
derived
Learn more about this trial
Fatigue Management Programs for People With MS
We'll reach out to this number within 24 hrs